A 133
Pill imprint A 133 has been identified as Bupropion hydrochloride extended release (SR) 150 mg.
Bupropion is used in the treatment of depression; smoking cessation; seasonal affective disorder; bipolar disorder; panic disorder (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy.
Bupropion 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Bupropion hydrochloride extended release (SR) Images
- Imprint:
-
A 133
- Strength:
- 150 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- copovidone
silicon dioxide colloidal
hydroxypropyl cellulose
hypromellose
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
titanium dioxide
triacetin
ferric oxide yellow
- Drug Class:
- Miscellaneous antidepressants
Smoking cessation agents - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 67767-0133
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0471 | Amerisource Health Services |
| 18837-0246 | Innoviant Pharmacy Inc (repackager) |
| 53002-1345 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
More Bupropion Hydrochloride Extended Release (SR) resources
- Bupropion Hydrochloride Extended Release (SR) Side Effects
- Bupropion Hydrochloride Extended Release (SR) Use in Pregnancy & Breastfeeding
- Bupropion Hydrochloride Extended Release (SR) Drug Interactions
- Support Group Q & A
- 319 Reviews for Bupropion Hydrochloride Extended Release (SR) - Add your own review/rating
- Bupropion
- Bupropion (Wolters Kluwer)
- Bupropion Extended-Release Tablets (Wolters Kluwer)
- Bupropion Hydrobromide Extended-Release Tablets (Wolters Kluwer)
- Bupropion Sustained-Release Tablets (Wolters Kluwer)
- bupropion (Cerner Multum)
- bupropion (Micromedex) - Includes Dosage Information
- Bupropion Hydrochloride (AHFS DI)
- Budeprion SR Tablets (FDA)
- Bupropion (FDA)
- Bupropion Tablets (FDA)
- Wellbutrin Tablets (FDA)
- Bupropion (Wolters Kluwer)
- Bupropion Hydrochloride (Wolters Kluwer)


